Evonik Industries AG - Company Profile
Powered by 
All the sales intelligence you need on Evonik Industries AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Evonik Industries AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Evonik Industries AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Evonik Industries AG (Evonik) is a company engaged in the development and production of specialty chemicals. The company's main activities include providing advanced technologies, custom solutions, and infrastructure services. Evonik's major products encompass high-performance polymers, crosslinkers, hydrogen peroxide, silicas, and additives for animal nutrition, and customized solutions like additives for coatings, adhesives, and pharmaceutical ingredients. The company serves a diverse range of industries including automotive, electronics, cosmetics, pharmaceuticals, and construction, offering products for applications such as coatings, lubricants, and medical devices. Evonik operates through a network of sites located in Germany, Slovakia, the USA, China, Singapore, Belgium, Austria, and Japan, targeting global markets. Evonik is headquartered in Essen, North Rhine-Westphalia, Germany.
Headquarters
Germany
Address
Rellinghauser Strasse 1-11, Essen, Nordrhein-Westfalen, 45128
Website
www.evonik.com
Telephone
49 201 17701
No of Employees
30,643
Industry
Chemicals
Ticker Symbol & Exchange
EVK (ETR)
Revenue (2024)
$15.9B
-7.2%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
19.4%
(2024 vs 2023)
Market Cap*
$8.5B
Net Profit Margin (2024)
XYZ
28.8%
(2024 vs 2023)
* As of and is in US$
Evonik Industries AG premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Polymers | Technical Support | Acematt |
| Crosslinkers | Logistics | Aerosil |
| Hydrogen Peroxide | Engineering | Acrifix |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Plans/Strategy | In June, the company announced its plans to sell selected production assets for pharmaceutical ingredients in Hanau, Germany to ProChem Group. |
| 2026 | Corporate Changes/Expansions | In June, the company opened the Asia Beauty Science & Innovation Center in Shanghai, China. |
| 2026 | New Products/Services | In June, the company launched peracetic acid to the European market with a significantly reduced carbon footprint, using a mass balance method aligned with ISO 22095-2:2026 and the TfS guideline 2024 and certified by TUV Rheinland. |
Competitor Comparison
| Key Parameters | Evonik Industries AG | BASF SE | Akzo Nobel NV | Eastman Chemical Co | DuPont de Nemours Inc |
|---|---|---|---|---|---|
| Headquarters | Germany | Germany | Netherlands | United States of America | United States of America |
| City | Essen | Ludwigshafen | Amsterdam | Kingsport | Wilmington |
| State/Province | Nordrhein-Westfalen | Rheinland-Pfalz | - | Tennessee | Delaware |
| No. of Employees | 30,643 | 106,428 | 31,100 | 13,000 | 15,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Christian Kullmann | Chairman; Chief Executive Officer | Executive Board | 2025 | 58 |
| Michael Rauch | Chief Financial Officer | Senior Management | 2026 | 54 |
| Thomas Wessel | Chief Human Resources Officer; Director - Labor Relations | Senior Management | 2011 | 63 |
| Alexander Bercht | Deputy Chairman | Non Executive Board | 2023 | 47 |
| Bernd Tonjes | Chairman - Supervisory Board | Non Executive Board | 2018 | 71 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer